HepGene, Inc. — Form D
HepGene, Inc. of FAIRFIELD, CT, a company, filed a Form D exempt-offering notice with the SEC on 2020-03-09. The offering totals $1.3M, of which $25K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-03-09
- Form: D
- Accession: 0001805892-20-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.3M
- Amount sold: $25K
- Remaining: $1.3M
- Minimum investment: $10K
- Investors: 1
- Date of first sale: 2020-03-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-362239
Issuer
- Name: HepGene, Inc.
- CIK: 0001805892
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 680 STILLSON ROAD, FAIRFIELD, CT, 06824
- Phone: 203-414-1723
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Martin J Keiser III | Director | Aliso Viejo, CA |
| Martin J Keiser Jr. | Director | Fairfield, CT |
| Patrick J Lilley | Director | Aliso Viejo, CA |
| Roland J Muduryan | Director | Aliso Viejo, CA |
| Steven J Van Fleet | Director | Fairfield, CT |
| Martin J Keiser III | Executive Officer | Aliso Viejo, CA |
More